Human Serum Dopamine-0-Hydroxylase

Serum dopamine-/3-hydroxylase activity varied from 3 to 581 units/ml in a group of 168 untreated adults (90 normals, 78 with borderline or overt hypertension). Levels did not correlate with blood pressure or age, but mean values were significantly lower in blacks than they were in whites. Subjects with exceptionally low levels of serum dopamine-/3-hydroxylase activity showed normal cardiovascular function and normal /3-hydroxylation of an administered synthetic substrate, hydroxyamphetamine. Pronounced blood pressure reduction by antihypertensive drugs did not change serum dopamine-/J-hydroxylase activity, and intensive bicycle exercise produced only small and variable increases. Two subjects with severe sympathetic dysfunction, i.e., orthostatic hypotension, showed normal levels of dopamine-/?-hydroxylase activity (89-123 units/ml). Serum dopamine-)6-hydroxylase activity varied from 450 to 950 units/ml in five subjects with pheochromocytomas and decreased to one-tenth the preoperative level in one subject who underwent curative surgery. Therefore, serum dopamine-/3-hydroxylase activity is not a satisfactory index of sympathetic function; moreover, activity levels do not correlate with prevailing blood pressure. Subjects with pheochromocytomas, however, may show increased serum levels of the enzyme, which demonstrates that such tumors can release dopamine-/3-hydroxylase.

[1]  M. Goldstein,et al.  Serum dopamine-beta-hydroxylase activity in neuroblastoma. , 1972, The New England journal of medicine.

[2]  R. Weinshilboum,et al.  Proportional Release of Norepinephrine and Dopamine-β-Hydroxylase from Sympathetic Nerves , 1971, Science.

[3]  R. Weinshilboum,et al.  Reduced plasma dopamine-beta-hydroxylase activity in familial dysautonomia. , 1971, The New England journal of medicine.

[4]  R. Weinshilboum,et al.  Serum Dopamine-β-Hydroxylase: Decrease after Chemical Sympathectomy , 1971, Science.

[5]  P. Molinoff,et al.  A sensitive enzymatic assay for dopamine- -hydroxylase. , 1971, The Journal of pharmacology and experimental therapeutics.

[6]  R. Weinshilboum,et al.  Elevation of Serum Dopamine-β-hydroxylase Activity with Forced Immobilization , 1971 .

[7]  R. Weinshilboum,et al.  Serum Dopamine‐Beta‐Hydroxylase Activity , 1971, Circulation research.

[8]  I. Kopin,et al.  Release of Dopamine-β-hydroxylase with Norepinephrine during Cat Splenic Nerve Stimulation , 1970, Nature.

[9]  K Engelman,et al.  V. CATECHOLAMINES CYCLIC AMP‐ANGIOTENSIN RECEPTORS: Plasma Catecholamine Concentrations in Patients with Hypertension , 1970, Circulation research.

[10]  R. Connett,et al.  Purification and properties of bovine phenylethanolamine N-methyltransferase. , 1970, The Journal of biological chemistry.

[11]  H. Winkler,et al.  Bovine splenic nerve: characterization of noradrenaline‐containing vesicles and other cell organelles by density gradient centrifugation , 1969, The Journal of physiology.

[12]  A. Sjoerdsma,et al.  DOPAMINE‐β‐OXIDASE ACTIVITY IN MAN, USING HYDROXYAMPHETAMINE AS SUBSTRATE , 1963 .

[13]  R. J. Whitney,et al.  The measurement of volume changes in human limbs , 1953, The Journal of physiology.

[14]  C. Bohuon,et al.  Dopamine beta hydroxylase (ec. 1.14.2.1) Dans le sang de souris porteuses d'un neuroblastome (c 1300). Relation avec la croissance tumorale. , 1971 .

[15]  A. Vendsalu Studies on adrenaline and noradrenaline in human plasma. , 1960, Acta physiologica Scandinavica. Supplementum.